Cargando…

Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model

BACKGROUND: Antibiotics have been overprescribed to treat infectious diseases and have generated antimicrobial resistances that reduce their effectiveness. Following the rationale behind the new paradigm of personalized medicine, point-of-care diagnostic testing (POCT) has been proposed to improve t...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoñanzas, F., Juárez-Castelló, C. A., Rodríguez-Ibeas, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351365/
https://www.ncbi.nlm.nih.gov/pubmed/34370115
http://dx.doi.org/10.1186/s13561-021-00326-y
_version_ 1783735959472308224
author Antoñanzas, F.
Juárez-Castelló, C. A.
Rodríguez-Ibeas, R.
author_facet Antoñanzas, F.
Juárez-Castelló, C. A.
Rodríguez-Ibeas, R.
author_sort Antoñanzas, F.
collection PubMed
description BACKGROUND: Antibiotics have been overprescribed to treat infectious diseases and have generated antimicrobial resistances that reduce their effectiveness. Following the rationale behind the new paradigm of personalized medicine, point-of-care diagnostic testing (POCT) has been proposed to improve the quality of antibiotic prescription with the aim of reducing antimicrobial resistances. METHODS: In order to understand whether this recommendation is valid, we create a theoretical economic model to determine under which conditions the expected benefits of using POCT to guide antibiotic prescription are greater than for empiric prescription, where we define the expected benefits as the difference between the economic value of health and the costs of the treatment. We consider the interaction of a group of physicians who express differing levels of uncertainty when prescribing with a firm selling a diagnostic device, and analyse the firm’s pricing policy and the physicians’ prescribing decisions. We allow the physicians to internalize the external costs of antimicrobial resistances. RESULTS: We find that the use of POCT reduces the number of antibiotic prescriptions. The reduction in antibiotic prescriptions is higher when physicians internalise the costs of antimicrobial resistances. Physicians with relatively high levels of uncertainty use POCT as they are uncertain about the right treatment for a large proportion of patients. Physicians with low levels of uncertainty prefer to prescribe empirically. The segmentation in the population of physicians regarding the uptake of POCT depends on the distribution of levels of uncertainty across physicians. For each test, the firm charges the marginal production costs of the inputs needed to administer the test, and makes its profit from the sales of the testing devices. CONCLUSIONS: From a theoretical perspective, our findings corroborate the fact that POCT improve the quality of antibiotic prescription and reduce the number of prescriptions. Nevertheless, their use is not always recommended as empiric therapy may be preferred when uncertainty is low.
format Online
Article
Text
id pubmed-8351365
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83513652021-08-09 Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model Antoñanzas, F. Juárez-Castelló, C. A. Rodríguez-Ibeas, R. Health Econ Rev Research BACKGROUND: Antibiotics have been overprescribed to treat infectious diseases and have generated antimicrobial resistances that reduce their effectiveness. Following the rationale behind the new paradigm of personalized medicine, point-of-care diagnostic testing (POCT) has been proposed to improve the quality of antibiotic prescription with the aim of reducing antimicrobial resistances. METHODS: In order to understand whether this recommendation is valid, we create a theoretical economic model to determine under which conditions the expected benefits of using POCT to guide antibiotic prescription are greater than for empiric prescription, where we define the expected benefits as the difference between the economic value of health and the costs of the treatment. We consider the interaction of a group of physicians who express differing levels of uncertainty when prescribing with a firm selling a diagnostic device, and analyse the firm’s pricing policy and the physicians’ prescribing decisions. We allow the physicians to internalize the external costs of antimicrobial resistances. RESULTS: We find that the use of POCT reduces the number of antibiotic prescriptions. The reduction in antibiotic prescriptions is higher when physicians internalise the costs of antimicrobial resistances. Physicians with relatively high levels of uncertainty use POCT as they are uncertain about the right treatment for a large proportion of patients. Physicians with low levels of uncertainty prefer to prescribe empirically. The segmentation in the population of physicians regarding the uptake of POCT depends on the distribution of levels of uncertainty across physicians. For each test, the firm charges the marginal production costs of the inputs needed to administer the test, and makes its profit from the sales of the testing devices. CONCLUSIONS: From a theoretical perspective, our findings corroborate the fact that POCT improve the quality of antibiotic prescription and reduce the number of prescriptions. Nevertheless, their use is not always recommended as empiric therapy may be preferred when uncertainty is low. Springer Berlin Heidelberg 2021-08-09 /pmc/articles/PMC8351365/ /pubmed/34370115 http://dx.doi.org/10.1186/s13561-021-00326-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Antoñanzas, F.
Juárez-Castelló, C. A.
Rodríguez-Ibeas, R.
Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
title Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
title_full Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
title_fullStr Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
title_full_unstemmed Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
title_short Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
title_sort using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351365/
https://www.ncbi.nlm.nih.gov/pubmed/34370115
http://dx.doi.org/10.1186/s13561-021-00326-y
work_keys_str_mv AT antonanzasf usingpointofcarediagnostictestingforimprovedantibioticprescriptionaneconomicmodel
AT juarezcastelloca usingpointofcarediagnostictestingforimprovedantibioticprescriptionaneconomicmodel
AT rodriguezibeasr usingpointofcarediagnostictestingforimprovedantibioticprescriptionaneconomicmodel